Reports
Global Musculoskeletal Pain Treatment Market Share, Size, Trends, Analysis: By Diagnosis Method: Blood Tests, X-Rays, MRI Scans, Others; By Treatment Type; By Pain Type; By Route of Administration; By Drug Type; By Population Type; By Treatment Channel; By End User; By Distribution Channel; Regional Analysis; Supplier Landscape; 2023-2031
Global Musculoskeletal Pain Treatment Market Outlook
The growth of the global musculoskeletal pain treatment market size was driven by the rising prevalence of the condition. The number of cases was close to 17.3 billion in 2022 and the prevalence is likely to continue growing at a CAGR of 30.5% during the forecast period of 2023-2031.
Musculoskeletal Pain Treatment Market: Introduction
Musculoskeletal pain is a condition where the patient experiences pain in the locomotor system, comprising of bones, joints, ligaments, muscles, and tendons. This pain might not be continuous and may come in intervals, but it is severe and makes it difficult for the people with this condition to perform physical activities smoothly. For some patients, the pain might be chronic. It can either effect one specific part or the entire body. Musculoskeletal pain is mostly caused due to traumatic incidents like sudden falls or jerking movements, accidents, fractures, sprains, dislocations, and direct blows to the muscle, ligament, or the bone. While these traumatic incidents account for most of the cases, the condition can also be caused due to daily activities or medical conditions like arthritis sometimes. Poor body mechanics and bad posture pose a severe threat to the muscular movement of the body. Other key factors responsible for causing this condition include repetitive movements, strain due to incorrect posture, overuse of a particular muscle, and prolonged immobilization of a body part.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The most common symptoms of this condition include pain in the bone, muscle, ligament, fatigue, and/or disturbed sleep due to pain. This pain can be tolerable or excruciating, depending upon the damage and the location of the injury. If the pain if mild and reduces within some weeks, then it is termed as acute pain, and if it is severe and lasts for months, then it is called chronic pain.
Musculoskeletal pain can also be caused due to some disorders in other vital parts like heart, spleen, lungs, gallbladder, and pancreas, among others. The pain can origin from these points and can radiate to the other parts of the body, like arms or legs. Such musculoskeletal pain is known as referred pain.
Musculoskeletal Pain Treatment Market Segmentation
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Diagnosis Method
- Blood Tests
- X-Rays
- MRI Scans
- Joint Fluid Tests
- Others
Market Breakup by Treatment Type
- Medications
- NSAIDS
- Ibuprofen
- Lornoxicam
- Naproxen
- Ketorolac
- Diclofenac
- Celecoxib
- Parecoxib
- Anticonvulsant
- Gabapentin
- Pregabalin
- Carbamazepine
- Others
- Antidepressants
- Amitriptyline
- Nortriptyline
- Duloxetine
- Others
- Opioids
- Endone
- Oxycontin
- Analgesics
- Acetaminophen
- Others
- Dexamethasone
- Prednisolone
- Lidocaine
- Lidocaine
- NSAIDS
- Surgery
Musculoskeletal Pain Treatment Market Breakup by Pain Type
- Bone Pain
- Joint Pain
- Muscle Pain
- Tendon and Ligament Pain
- Others
Market Breakup by Route of Administration
- Oral
- Tablets
- Capsules
- Parentals
- Intravenous
- Intramuscular
- Intrathecal
- Topicals
- Others
Market Breakup by Drug Type
- Over the Counter
- Prescription
- Branded
- Generics
Market Breakup by Population Type
- Adults
- Male
- Female
- Geriatrics
- Male
- Female
Market Breakup by Treatment Channel
- Public
- Private
Market Breakup by End User
- Hospitals
- Specialty Clinics
- Homecare Settings
- Others
Market Breakup by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Market Breakup by Region
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Musculoskeletal Pain Treatment Market Overview
The growth of the market is being driven by the rising cases of accidents as well as rising demand for surgeries, leading to musculoskeletal pain. Rapid technological advancements in the healthcare industry, supported by government initiatives, is further propelling the growth of the market. Based on regions, North America is anticipated to account for the largest market share owing to the developed healthcare sector, supported by the presence of industry leaders in the region. The increasing prevalence of arthritis in the region is also a key factor contributing to the growth of the musculoskeletal pain treatment market in the region. The rising technological advancements as well as clinical trials is likely to aid the growth of the market in the coming years.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Musculoskeletal Pain Treatment Market- Epidemiology
The recent study on the Global Burden of Disease (GBD) 2019 states that nearly 1.71 billion were diagnosed with musculoskeletal pain. This condition significantly contributes to the number of disabled people across the globe, with lower back pain being the leading type in nearly 160 countries. Geriatric population is more vulnerable to this condition than young people as the bones become weaker as they age.
People earning higher incomes are a higher risk of suffering from the disease due to their inactive lifestyles. However, the number of people suffering from musculoskeletal pain is likely to rise rapidly in the coming years, especially in the low- and middle-income regions. Women are twice as likely as men to suffer from musculoskeletal diseases.
Musculoskeletal Pain Treatment Market- Therapeutic Landscape
There are various treatments available for musculoskeletal pain in the treatment market. These treatments include medications and/ or surgeries like occupational therapy, acupuncture, chiropractic adjustment, pain relievers, physical therapy, splints, physical therapy, therapeutic massage, and steroid injections, among others.
The most common medications used for the treatment include Acetaminophen (Tylenol®), nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin, ibuprofen (Advil, Motrin), or naproxen (Aleve), and prescription medications, such as opioids. Prescription drugs that are used to aid sleep include zolpidem (Ambien), ramelteon (Rozerem), and eszopiclone (Lunesta).
Key Players in the Global Musculoskeletal Pain Treatment Market
The major companies working on the drugs and treatment of musculoskeletal pain and investing in the clinical trials include the following:
- Pfizer Inc.
- Abbvie Inc.
- Novartis AG
- Amgen Inc.
- Boehringer Ingelheim International GmbH.
- Merck & Co Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceuticals Industries Ltd.
- AstraZeneca
- Ampio Pharmaceuticals Inc.
- Eli Lilly and Company
- Novartis International AG
- Sanofi S.A.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2016-2022 |
| Forecast Period | 2023-2031 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Diagnosis Method |
|
| Breakup by Treatment Type |
|
| Breakup by Pain Type |
|
| Breakup by Route of Administration |
|
| Breakup by Drug Type |
|
| Breakup by Population Type |
|
| Breakup by Treatment Channel |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Musculoskeletal Pain Diseases Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Musculoskeletal Pain Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Musculoskeletal Pain Epidemiology (2016-2031)
5.3 Europe Musculoskeletal Pain Epidemiology (2016-2031)
5.4 Asia-Pacific Musculoskeletal Pain Epidemiology (2016-2031)
5.5 Latin America Musculoskeletal Pain Epidemiology (2016-2031)
5.6 Middle East & Africa Musculoskeletal Pain Epidemiology (2016-2031)
6 Global Musculoskeletal Pain Treatment Market Overview
6.1 Global Musculoskeletal Pain Treatment Market Historical Value (2016-2022)
6.2 Global Musculoskeletal Pain Treatment Market Forecast Value (2023-2031)
7 Global Musculoskeletal Pain Treatment Market Landscape
7.1 Musculoskeletal Pain Treatment: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
8 Musculoskeletal Pain Treatment Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Musculoskeletal Pain Treatment Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Musculoskeletal Pain Treatment Market Segmentation
11.1 Global Musculoskeletal Pain Treatment Market by Diagnosis Method
11.1.1 Market Overview
11.1.2 Blood Tests
11.1.3 X-Rays
11.1.4 MRI Scans
11.1.5 Joint Fluid Tests
11.1.6 Others
11.2 Global Musculoskeletal Pain Treatment Market by Treatment Type
11.2.1 Market Overview
11.2.2 Medications
11.2.2.1 NSAIDS
11.2.2.1.1 Ibuprofen
11.2.2.1.2 Lornoxicam
11.2.2.1.3 Naproxen
11.2.2.1.4 Ketorolac
11.2.2.1.5 Diclofenac
11.2.2.1.6 Celecoxib
11.2.2.1.7 Parecoxib
11.2.2.2 Anticonvulsant
11.2.2.2.1 Gabapentin
11.2.2.2.2 Pregabalin
11.2.2.2.3 Carbamazepine
11.2.2.2.4 Others
11.2.2.3 Antidepressants
11.2.2.3.1 Amitriptyline
11.2.2.3.2 Nortriptyline
11.2.2.3.3 Duloxetine
11.2.2.3.4 Others
11.2.2.4 Opioids
11.2.2.4.1 Endone
11.2.2.4.2 Oxycontin
11.2.2.5 Analgesics
11.2.2.5.1 Acetaminophen
11.2.2.6 Others
11.2.2.6.1 Dexamethasone
11.2.2.6.2 Prednisolone
11.2.2.6.3 Lidocaine
11.2.2.6.4 Lidocaine
11.2.3 Surgery
11.3 Global Musculoskeletal Pain Treatment Market by Pain Type
11.3.1 Market Overview
11.3.2 Bone Pain
11.3.3 Joint Pain
11.3.4 Muscle Pain
11.3.5 Tendon and Ligament Pain
11.3.6 Others
11.4 Global Musculoskeletal Pain Treatment Market by Route of Administration
11.4.1 Market Overview
11.4.2 Oral
11.4.2.1 Tablets
11.4.2.2 Capsules
11.4.3 Parentals
11.4.3.1 Intravenous
11.4.3.2 Intramuscular
11.4.3.3 Intrathecal
11.4.4 Topicals
11.4.5 Others
11.5 Global Musculoskeletal Pain Treatment Market by Drug Type
11.5.1 Market Overview
11.5.2 Over the Counter
11.5.3 Prescription
11.5.3.1 Branded
11.5.3.2 Generics
11.6 Global Musculoskeletal Pain Treatment Market by Population Type
11.6.1 Market Overview
11.6.2 Adults
11.6.2.1 Male
11.6.2.2 Female
11.6.3 Geriatrics
11.6.3.1 Male
11.6.3.2 Female
11.7 Global Musculoskeletal Pain Treatment Market by Treatment Channel
11.7.1 Market Overview
11.7.2 Public
11.7.3 Private
11.8 Global Musculoskeletal Pain Treatment Market by End User
11.8.1 Market Overview
11.8.2 Hospitals
11.8.3 Specialty Clinics
11.8.4 Homecare Settings
11.8.5 Others
11.9 Global Musculoskeletal Pain Treatment Market by Distribution Channel
11.9.1 Market Overview
11.9.2 Hospital Pharmacy
11.9.3 Retail Pharmacy
11.9.4 Online Pharmacy
11.9.5 Others
11.10 Global Musculoskeletal Pain Treatment Market by Region
11.10.1 Market Overview
11.10.2 North America
11.10.3 Europe
11.10.4 Asia Pacific
11.10.5 Latin America
11.10.6 Middle East and Africa
12 North America Musculoskeletal Pain Treatment Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Musculoskeletal Pain Treatment Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Musculoskeletal Pain Treatment Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Musculoskeletal Pain Treatment Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Musculoskeletal Pain Treatment Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 Pfizer Inc.
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Abbvie Inc.
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Novartis AG
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Amgen Inc.
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 Boehringer Ingelheim International GmbH.
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Merck & Co Inc.
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Sun Pharmaceutical Industries Ltd.
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Teva Pharmaceuticals Industries Ltd.
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 AstraZeneca
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 Ampio Pharmaceuticals Inc.
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
23.11 Eli Lilly and Company
23.11.1 Financial Analysis
23.11.2 Product Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Mergers and Acquisitions
23.11.5 Certifications
23.12 Novartis International AG
23.12.1 Financial Analysis
23.12.2 Product Portfolio
23.12.3 Demographic Reach and Achievements
23.12.4 Mergers and Acquisitions
23.12.5 Certifications
23.13 Sanofi S.A.
23.13.1 Financial Analysis
23.13.2 Product Portfolio
23.13.3 Demographic Reach and Achievements
23.13.4 Mergers and Acquisitions
23.13.5 Certifications
24 Musculoskeletal Pain Treatment - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The growth of the market was driven by the rising prevalence of musculoskeletal pain, the number of musculoskeletal pain cases reached 17.3 billion in 2022.
The growth of the market is likely to be driven by the rising prevalence of the disease, which is anticipated to grow at a CAGR of 30.5% during the forecast period of 2023-2031.
The growth of the market is driven by factors like rising prevalence of the disease, triggered by long hours of inactivity, traumatic incidents, and old age, among others.
The rising availability of affordable treatments is a key trend in the market.
The diagnosis methods include blood tests, X-rays, MRI scans, and joint fluid tests, among others.
The treatment methods used for the treatment include medications and surgery.
The pain type can be categorized into bone pain, joint pain, muscle pain, tendon and ligament pain, among others.
The different routes of administration include oral, parentals, and topicals, among others.
The drug types used in the treatment include over the counter and prescription.
The population types include adults and geriatrics, including both male and female.
The treatment channels can be categorised into public and private channels.
The end-user segments include hospitals, specialty clinics, and homecare settings, among others.
The treatment channels can be categorised into hospital pharmacy, retail pharmacy, and online pharmacy, among others.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major players in the market are A Pfizer Inc., Abbvie Inc., Novartis AG, Amgen Inc., Boehringer Ingelheim International GmbH., Merck & Co Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Industries Ltd., AstraZeneca, Ampio Pharmaceuticals Inc., Eli Lilly and Company, Novartis International AG, and Sanofi S.A., among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$3499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$5999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$7999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$9999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER